These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 28322788)
21. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic. Jakubec P; Pelclova D; Smolkova P; Kolek V; Nakladalova M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):472-9. PubMed ID: 24781044 [TBL] [Abstract][Full Text] [Related]
22. Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. Hollevoet K; Reitsma JB; Creaney J; Grigoriu BD; Robinson BW; Scherpereel A; Cristaudo A; Pass HI; Nackaerts K; Rodríguez Portal JA; Schneider J; Muley T; Di Serio F; Baas P; Tomasetti M; Rai AJ; van Meerbeeck JP J Clin Oncol; 2012 May; 30(13):1541-9. PubMed ID: 22412141 [TBL] [Abstract][Full Text] [Related]
23. Mesothelin in serum and pleural effusion in the diagnosis of malignant pleural mesothelioma with non-positive cytology. Franceschini MC; Ferro P; Canessa PA; Battolla E; Dessanti P; Valentino A; Casolari L; Fontana V; Pezzi R; Fedeli F; Pistillo MP; Roncella S Anticancer Res; 2014 Dec; 34(12):7425-9. PubMed ID: 25503183 [TBL] [Abstract][Full Text] [Related]
24. Comparison of fibulin-3 and mesothelin as markers in malignant mesothelioma. Creaney J; Dick IM; Meniawy TM; Leong SL; Leon JS; Demelker Y; Segal A; Musk AW; Lee YC; Skates SJ; Nowak AK; Robinson BW Thorax; 2014 Oct; 69(10):895-902. PubMed ID: 25037982 [TBL] [Abstract][Full Text] [Related]
25. Novel ELISA system for detection of N-ERC/mesothelin in the sera of mesothelioma patients. Shiomi K; Miyamoto H; Segawa T; Hagiwara Y; Ota A; Maeda M; Takahashi K; Masuda K; Sakao Y; Hino O Cancer Sci; 2006 Sep; 97(9):928-32. PubMed ID: 16776777 [TBL] [Abstract][Full Text] [Related]
27. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma. Santarelli L; Staffolani S; Strafella E; Nocchi L; Manzella N; Grossi P; Bracci M; Pignotti E; Alleva R; Borghi B; Pompili C; Sabbatini A; Rubini C; Zuccatosta L; Bichisecchi E; Valentino M; Horwood K; Comar M; Bovenzi M; Dong LF; Neuzil J; Amati M; Tomasetti M Lung Cancer; 2015 Dec; 90(3):457-64. PubMed ID: 26431916 [TBL] [Abstract][Full Text] [Related]
28. Plasma versus serum levels of osteopontin and mesothelin in patients with malignant mesothelioma--which is best? Creaney J; Yeoman D; Musk AW; de Klerk N; Skates SJ; Robinson BW Lung Cancer; 2011 Oct; 74(1):55-60. PubMed ID: 21397972 [TBL] [Abstract][Full Text] [Related]
29. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers. Johnen G; Burek K; Raiko I; Wichert K; Pesch B; Weber DG; Lehnert M; Casjens S; Hagemeyer O; Taeger D; Brüning T; Sci Rep; 2018 Sep; 8(1):14321. PubMed ID: 30254313 [TBL] [Abstract][Full Text] [Related]
30. Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos. Filiberti R; Marroni P; Spigno F; Merlo DF; Mortara V; Caruso P; Cioè A; Michelazzi L; Bruzzone A; Bobbio B; Simonassi C; Del Corso L; Galli R; Racchi O; Dini G; Linares R; Mencoboni M Oncology; 2014; 86(1):33-43. PubMed ID: 24401539 [TBL] [Abstract][Full Text] [Related]
31. Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers. Felten MK; Khatab K; Knoll L; Schettgen T; Müller-Berndorff H; Kraus T Int Arch Occup Environ Health; 2014 Feb; 87(2):195-204. PubMed ID: 23423281 [TBL] [Abstract][Full Text] [Related]
32. Serum mesothelin for early detection of asbestos-induced cancer malignant mesothelioma. Creaney J; Olsen NJ; Brims F; Dick IM; Musk AW; de Klerk NH; Skates SJ; Robinson BW Cancer Epidemiol Biomarkers Prev; 2010 Sep; 19(9):2238-46. PubMed ID: 20651076 [TBL] [Abstract][Full Text] [Related]
34. Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure. Demir M; Kaya H; Taylan M; Ekinci A; Yılmaz S; Teke F; Sezgi C; Tanrikulu AC; Meteroglu F; Senyigit A Lung; 2016 Jun; 194(3):409-17. PubMed ID: 27032653 [TBL] [Abstract][Full Text] [Related]
35. Malignant Mesothelioma Biomarkers: From Discovery to Use in Clinical Practice for Diagnosis, Monitoring, Screening, and Treatment. Creaney J; Robinson BWS Chest; 2017 Jul; 152(1):143-149. PubMed ID: 28007619 [TBL] [Abstract][Full Text] [Related]